Our panellists will present a prostate cancer case study and discuss the patient's journey from each of their speciality perspectives including PSA testing, risk factors for prostate cancer, different cancer risk categories, when to refer, MRI, biopsy, treatment options and side effects, survivorship and penile rehab.
Date: Wednesday 26 October 2022
Time: 6.30pm-9.00pm
Program:
6.30-7.00pm: registration and dinner
7.00-8.45pm: presentation & panel discussion
8.45-9.00pm: Q&A
Specialist Panel
Dr Jane Crowe, Prostate Cancer GP and Moderator
Mr Phil Dundee, Urological Surgeon
Dr Mario Guerrieri, Radiation Oncologist
Prof Rod Hicks, Nuclear Medicine Physician
Ms Helen Crowe AM, Urology Nurse Practitioner
Learning Outcomes
By the end of this activity, participants will be able to:
1. Identify the risk factors for prostate cancer.
2. Determine the GP management of male patients with an elevated prostate specific antigen (PSA) with or without urinary symptoms.
3. Discuss the management of male patients with an elevated PSA following referral to a urologist.
4. Highlight prostate cancer survivorship concerns that GPs come across in the general practice setting.
RACGP
Four CPD activity points.
Registration
Limited places available. When registering, please provide the information below:
- First name and last name
- Practice name, suburb and postcode
- Email address
- RACGP number
- Occupation
- Any dietary requirements
Enquiries
Grace Linehan, Medical Liaison Officer
E: grace.linehan@apcr.org.au
M: 0400 976 196
This event is sponsored by Ipsen.
